959 related articles for article (PubMed ID: 25321320)
41. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
42. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration.
Cydulka RK; Rowe BH; Clark S; Emerman CL; Camargo CA;
J Am Geriatr Soc; 2003 Jul; 51(7):908-16. PubMed ID: 12834509
[TBL] [Abstract][Full Text] [Related]
43. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines.
Lodewijckx C; Sermeus W; Vanhaecht K; Panella M; Deneckere S; Leigheb F; Decramer M
J Eval Clin Pract; 2009 Dec; 15(6):1101-10. PubMed ID: 20367712
[TBL] [Abstract][Full Text] [Related]
44. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.
Halpin DMG; Criner GJ; Papi A; Singh D; Anzueto A; Martinez FJ; Agusti AA; Vogelmeier CF
Am J Respir Crit Care Med; 2021 Jan; 203(1):24-36. PubMed ID: 33146552
[TBL] [Abstract][Full Text] [Related]
45. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
46. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
47. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
[TBL] [Abstract][Full Text] [Related]
48. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
[TBL] [Abstract][Full Text] [Related]
49. The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment.
Aaron SD; Vandemheen K; Fergusson D; Fitzgerald M; Maltais F; Bourbeau J; Goldstein R; McIvor A; Balter M; O'donnell D
Can Respir J; 2004; 11(8):581-5. PubMed ID: 15611808
[TBL] [Abstract][Full Text] [Related]
50. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
51. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
52. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
53. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
Fraser A; Poole P
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
[TBL] [Abstract][Full Text] [Related]
54. Management of COPD exacerbations in primary care: a clinical cohort study.
Sundh J; Österlund Efraimsson E; Janson C; Montgomery S; Ställberg B; Lisspers K
Prim Care Respir J; 2013 Dec; 22(4):393-9. PubMed ID: 24114334
[TBL] [Abstract][Full Text] [Related]
55. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
56. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
57. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
[TBL] [Abstract][Full Text] [Related]
58. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
59. Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey.
Barnes N; Calverley PM; Kaplan A; Rabe KF
Curr Med Res Opin; 2014 Apr; 30(4):667-84. PubMed ID: 24256026
[TBL] [Abstract][Full Text] [Related]
60. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
Trials; 2012 Apr; 13():40. PubMed ID: 22520863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]